Users online: 6103    [ij] [ij] [ij] 
Email id

Year : 2017, Volume : 4, Issue : 1
First page : ( 18) Last page : ( 23)
Print ISSN : 2322-0414. Online ISSN : 2322-0422. Published online : 2017  1.
Article DOI : 10.5958/2322-0422.2017.00004.2

Prevalence of HIV-2 Infection Among Clients Attending Integrated Counselling and Testing Centre of a Teaching Institute in Kolhapur, India

Chougale Roma1,,*, Nikam Vasudha2

1Associate Professor, Department of Microbiology, D.Y. Patil University, D.Y. Patil Medical College, Kolhapur-416006, Maharashtra, India

2Professor and Head, Department of Anatomy, D.Y. Patil University, D.Y. Patil Medical College, Kolhapur-416006, Maharashtra, India

(*Corresponding author) email id: *neetiroma@gmail.com; 2Dr.vasudhanikam@gmail.com


Background: Though human immunodeficiency virus (HIV)-1 is the predominant HIV virus in India, cases of HIV-2 are also reported sporadically. Known as a silent killer, HIV-2 strain can remain undetected in the body for five to six years. If a person does not get treatment on time, death is imminent. Objectives: This study aimed at finding out the prevalence of HIV-2 infection at our centre. Methods: Retrospective analysis of data of clients who attended the Integrated Counselling and Testing Centre (ICTC), in D.Y. Patil University's Medical College and Hospital, Kolhapur, Maharashtra, India, from April 2013 to March 2017 was carried out. Three rapid test algorithm was used to diagnose HIV 1, HIV-2 and HIV-1+2 co-infections. Results: A total of 13,102 patients were included in the analysis over a four-year period. Out of the 162 patients reported HIV positive, 1.18%, 0.02% and 0.03% were HIV-1 infected, (HIV-1+2–), HIV-2 infected (HIV-1–2+) and HIV-1 and HIV-2 co-infected (HIV-1+2+), respectively. Conclusion: Continued surveillance is needed to monitor HIV-2 in the population because the possibility for further spread of HIV-2 exists, especially among people with multiple sex partners. Accurate treatment and follow-up are needed to prevent future hazards of drug resistance.



Antiretroviral therapy (ART), HIV seropositives, HIV-related opportunistic infections, Human immunodeficiency virus (HIV), Infections, Integrated couselling and testing centre (ICTC), Protease inhibitors.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
565,852,644 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.